Detalles de la búsqueda
1.
Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study.
Ann Rheum Dis;
74(8): 1567-70, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25873635
2.
Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O).
J Clin Rheumatol;
21(5): 231-8, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26203826
3.
Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis.
Toxicol Sci;
2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38588579
4.
Treatment and biologic maintenance-dosing patterns among pediatric patients with ulcerative colitis or Crohn's disease.
Curr Med Res Opin;
39(1): 63-69, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263735
5.
The Role of Master Protocols in Pediatric Drug Development.
Ther Innov Regul Sci;
56(6): 895-902, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36045315
6.
Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn's Disease Receiving Biologics: A Retrospective Cohort Study.
Crohns Colitis 360;
4(2): otac009, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36777044
7.
Acute lymphoid and gastrointestinal toxicity induced by selective p38alpha map kinase and map kinase-activated protein kinase-2 (MK2) inhibitors in the dog.
Toxicol Pathol;
38(4): 606-18, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20448081
8.
Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy.
Arthritis Res Ther;
21(1): 102, 2019 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30999933
9.
A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitis.
J Patient Rep Outcomes;
3(1): 66, 2019 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31667633
10.
Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab.
Arthritis Rheumatol;
69(3): 643-654, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27723281
11.
Fully human anti-BAFF inhibitory monoclonal antibody tabalumab does not adversely affect T-dependent antibody responses in cynomolgus monkey (Macaca fasicularis): A summary of three pre-clinical immunotoxicology evaluations.
J Immunotoxicol;
13(1): 7-19, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-25585959
12.
A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritis.
Arthritis Res Ther;
16(4): 415, 2014 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25168268
13.
Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations.
J Immunotoxicol;
9(2): 210-30, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22428536
14.
A Highly Sensitive and Drug-Tolerant Anti-Drug Antibody Screening Assay for Ixekizumab using Affinity Capture Elution.
J Invest Dermatol;
136(7): 1513-1515, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27039261
15.
BAFF inhibition does not significantly impair immunization responses in patients with rheumatoid arthritis.
Arthritis Res Ther;
17: 347, 2015 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-26621128
16.
Screening New Drugs for Immunotoxic Potential: II. Assessment of the Effects of Selective and Nonselective COX-2 Inhibitors on Complement Activation, Superoxide Anion Production and Leukocyte Chemotaxis and Migration Through Endothelial Cells.
J Immunotoxicol;
2(2): 85-96, 2005 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18958662
17.
Screening new drugs for immunotoxic potential: III. assessment of the effects of selective and nonselective COX-2 inhibitors on T-cell-dependent antibody and natural killer cell responses in the rat.
J Immunotoxicol;
2(3): 161-70, 2005 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18958669
18.
Screening New Drugs for Immunotoxic Potential: I. Assessment of the Effects of Conventional Nonsteroidal Anti-Inflammatory Drugs and Selective COX-2 Inhibitors on In Vitro and In Vivo Phagocytic Activity.
J Immunotoxicol;
1(3): 149-58, 2005 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18958648
Resultados
1 -
18
de 18
1
Próxima >
>>